Copertina

Developing a predictive signature for two trial endpoints using the cross-validated risk scores method

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Cherlin, Svetlana, Wason, James M. S.
Natura:	Preprint
Pubblicazione:	2020
Soggetti:	Methodology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cross-validated risk scores adaptive enrichment (CADEN) design
di: Cherlin, Svetlana, et al.
Pubblicazione: (2021)

Augmented Binary Method for Basket Trials (ABBA)
di: Cherlin, Svetlana, et al.
Pubblicazione: (2024)

Differences in Performance of Bayesian Dynamic Borrowing and Synthetic Control Methods: A Case Study of Pediatric Atopic Dermatitis
di: Cizauskas, Nicole, et al.
Pubblicazione: (2026)

Evaluating the impact of outcome delay on the efficiency of two-arm group-sequential trials
di: Mukherjee, Aritra, et al.
Pubblicazione: (2023)

Optimal Bayesian stepped-wedge cluster randomised trial designs for binary outcome data
di: Etfer, Laura, et al.
Pubblicazione: (2024)

Power calculation for cross-sectional stepped wedge cluster randomized trials with a time-to-event endpoint
di: Baumann, Mary Ryan, et al.
Pubblicazione: (2023)

Fast and robust cross-validation-based scoring rule inference for spatial statistics
di: Olafsdottir, Helga Kristin, et al.
Pubblicazione: (2024)

Sample size calculations for multilevel factorial longitudinal cluster randomised trials
di: Bowden, Rhys, et al.
Pubblicazione: (2025)

Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trials
di: Wolf, Jack M., et al.
Pubblicazione: (2025)

Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights
di: Whitehead, Lou E., et al.
Pubblicazione: (2024)

Estimation of treatment effect in clinical trials of continuous endpoints with retrieved dropouts
di: Kang, Myeongjong, et al.
Pubblicazione: (2026)

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints
di: Owen, Melody, et al.
Pubblicazione: (2025)

Evaluating the impact of outcome delay on the efficiency of sample size re-estimation
di: Mukherjee, Aritra, et al.
Pubblicazione: (2026)

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
di: Wolbers, Marcel, et al.
Pubblicazione: (2024)

Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints
di: Smith, E. Davies, et al.
Pubblicazione: (2024)

Combining missing data imputation and internal validation in clinical risk prediction models
di: Mi, Junhui, et al.
Pubblicazione: (2024)

Uncertainty of high-dimensional genetic data prediction with polygenic risk scores
di: Fu, Haoxuan, et al.
Pubblicazione: (2024)

Graph fission and cross-validation
di: Leiner, James, et al.
Pubblicazione: (2024)

Explaining the optimistic performance evaluation of newly proposed methods: a cross-design validation experiment
di: Nießl, Christina, et al.
Pubblicazione: (2022)

Moving beyond spatial and random cross-validation in environmental modelling: a call for prediction-domain adaptive evaluation
di: Linnenbrink, Jan, et al.
Pubblicazione: (2026)

A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders
di: Xu, Xiaoming, et al.
Pubblicazione: (2024)

Bayesian sample size calculations for external validation studies of risk prediction models
di: Sadatsafavi, Mohsen, et al.
Pubblicazione: (2025)

Large language model validity via enhanced conformal prediction methods
di: Cherian, John J., et al.
Pubblicazione: (2024)

A review of regularised estimation methods and cross-validation in spatiotemporal statistics
di: Otto, Philipp, et al.
Pubblicazione: (2024)

On cross-validated estimation of skew normal model
di: Zhang, Jian, et al.
Pubblicazione: (2024)

Estimation of density functionals via cross-validation
di: Chacón, José E., et al.
Pubblicazione: (2024)

On cross-validation for small area estimators
di: Dong, Qianyu, et al.
Pubblicazione: (2026)

"Within-trial" prognostic score adjustment is targeted maximum likelihood estimation
di: Højbjerre-Frandsen, Emilie, et al.
Pubblicazione: (2025)

Generalized win fraction regression for composite survival endpoints
di: Cao, Zhiqiang, et al.
Pubblicazione: (2026)

Utilising high-dimensional data in randomised clinical trials: a review of methods and practice
di: Cherlin, Svetlana, et al.
Pubblicazione: (2023)

The risks of risk assessment: causal blind spots when using prediction models for treatment decisions
di: van Geloven, Nan, et al.
Pubblicazione: (2024)

Bayesian cross-validation by parallel Markov Chain Monte Carlo
di: Cooper, Alex, et al.
Pubblicazione: (2023)

Improving operating characteristics of clinical trials by augmenting control arm using propensity score-weighted borrowing-by-parts power prior
di: Das, Apu Chandra, et al.
Pubblicazione: (2026)

Model validation for aggregate inferences in out-of-sample prediction
di: Kennedy, Lauren, et al.
Pubblicazione: (2023)

While-alive regression analysis of composite survival endpoints
di: Fang, Xi, et al.
Pubblicazione: (2025)

How to develop, externally validate, and update multinomial prediction models
di: Gehringer, Celina K, et al.
Pubblicazione: (2023)

Joint leave-group-out cross-validation in Bayesian spatial models
di: Cooper, Alex, et al.
Pubblicazione: (2025)

A simple strategy for valid inference in target trial emulations
di: Stensrud, Mats Julius
Pubblicazione: (2026)

Unified optimal model averaging with a general loss function based on cross-validation
di: Yu, Dalei, et al.
Pubblicazione: (2024)

Clinical research and methodology What usage and what hierarchical order for secondary endpoints?
di: Laporte, Silvy, et al.
Pubblicazione: (2024)